Digital therapies are proving particularly useful in pathological conditions linked to behavioural and psychological factors, such as Alzheimer’s, dementia, type II diabetes, and even serious respiratory problems. Let’s take a look at how they are made, how they work, the indications and market perspectives.
According to a Juniper Research study, the number of people using therapeutic and wellness applications will increase from 627 million in 2020 to more than 1.4 billion in 2025.
Eleven months after the approval of the Digital Versorgung Gesetz (DVG), the Digital Health Care Act (DVG), two apps are now prescribed by German doctors.
German Health Minister Jens Spahn has announced an extraordinary investment plan for health care.
Akili Interactive has received De Novo marketing authorization from the FDA for EndeavorRx, a therapeutic video game for children aged 8-12 years with ADHD (Attention Deficit Disorder/Hyperactivity Disorder).
The law promotes telemedicine and foresees the reimbursement of medical apps.
On 8 November, the German Bundestag passed the Digitale-Versorgung-Gesetz (DVG), a law for greater digitisation of the health system. Continue reading
The topic was discussed at the DTx East conference in Boston where the risk assessment of digital therapies, how these risks differ from traditional drugs and how these differences could affect regulation were discussed. Continue reading
Virtual therapeutic reality is an effective clinical practice for pain management. A study published in the journal Plos One measures the impact and effectiveness of this therapy. Continue reading
A very interesting field of digital health is the “digital therapeutics”, a new frontier for people care, in addition to pharmacological and psychological therapies. Continue reading